Scientific article
Open access

Mise au point sur le traitement de la sarcoïdose

Published inRevue médicale suisse, vol. 12, no. 539, p. 1966-1971
Publication date2016

Sarcoidosis is a granulomatous disease characterized by variable manifestations and course. About 50% of patients will require systemic treatment, while the remaining will present spontaneous resolution of the disease. When a systemic therapy is necessary, it is prolonged and relapse rate is high when it is discontinued. Systemic corticosteroids are the first line treatment in sarcoidosis. Because of many side effects, it is essential to consider other drugs in case of intolerance to steroids, as steroid-sparing agents, or in case of inefficiency of corticotherapy alone.

  • Glucocorticoids/adverse effects/therapeutic use
  • Humans
  • Recurrence
  • Sarcoidosis/drug therapy/physiopathology
Citation (ISO format)
ROCHAT, Tamara et al. Mise au point sur le traitement de la sarcoïdose. In: Revue médicale suisse, 2016, vol. 12, n° 539, p. 1966–1971.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation11/01/2018 4:23:00 PM
First validation11/01/2018 4:23:00 PM
Update time03/15/2023 1:50:54 PM
Status update03/15/2023 1:50:54 PM
Last indexation01/17/2024 4:08:58 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack